Skip to main content

Table 5 Influencing factors and motivators to research participation and barriers to retention: drug of choice differences, heroin vs. methamphetamine

From: A cross-sectional survey of potential factors, motivations, and barriers influencing research participation and retention among people who use drugs in the rural USA

Survey item

Heroin (n = 90)

Methamphetamine (n = 91)

Prevalence ratioa,b

95% CI

Selected

not selected

selected

not selected

Influencing factors

 What the research study involves (e.g., survey, drug testing for research)

69

21

68

23

0.96

(0.86, 1.06)

 How much time is required

67

23

58

33

0.91

(0.79, 1.03)

 How often they have to come in for visits

57

33

56

35

0.90

(0.78, 1.05)

 How far they have to travel to participate (i.e., nearby vs. out of town)

58

32

67

24

1.01

(0.90, 1.13)

 Privacy of the research office

58

32

73

18

1.10

(0.99, 1.20)

 Why their information is being collected and what it will be used for

53

37

67

24

1.12*

(1.00, 1.26)

 Whether their information will be kept confidential

63

27

80

11

1.07

(0.99, 1.16)

 Whether the staff doing the research is friendly and trustworthyc

62

28

82

9

 Whether the research institution or university is respected

39

51

51

40

1.25*

(1.08, 1.43)

 Whether they can skip questions of parts of the study that make them uncomfortable

51

39

61

30

1.04

(0.91, 1.19)

 How much money they will receive

64

26

75

16

1.01

(0.92, 1.11)

 How much the project will benefit them overall

58

32

68

23

0.93

(0.82, 1.05)

 Whether their appointment times will interfere with their work schedule

37

53

42

49

1.07

(0.88, 1.30)

 Whether they have childcare so that they can attend their appointments

41

49

51

40

1.08

(0.91, 1.28)

 How their friends, family, or partner feels about them participating

38

52

46

45

1.09

(0.90, 1.31)

Motivations

 Financial incentive (i.e., money or gift card given for participation

79

11

81

10

0.97

(0.91, 1.04)

 They believe in the mission of the research and want to contribute

61

29

64

27

0.93

(0.82, 1.06)

 Their friends, family, or partner participates

63

27

67

24

0.93

(0.82, 1.04)

 They want to tell their story

49

41

54

37

1.03

(0.88, 1.20)

 They know someone on the research team and want to help them out

27

63

37

54

1.00

(0.79, 1.28)

 They want to learn about the topic

43

47

57

34

1.05

(0.90, 1.23)

 They would want to get free testing (for example, rapid tests for HIV & Hepatitis C) if it was offered as part of the study

55

35

78

13

1.08

(0.99, 1.18)

 They would want to be linked with resources and/or follow-up testing if it was offered as part of the study

55

35

73

18

1.09

(0.99, 1.21)

 They would want to try a new treatment if it was offered as part of the study

59

31

76

15

1.03

(0.93, 1.13)

 Their friends, family, or partner pressures them to participate so that they can share the financial incentive

34

56

32

59

0.88

(0.69, 1.13)

Barriers

 Not being able to get in touch with participants because their contact information changed

72

18

80

11

1.00

(0.93, 1.08)

 Not being able to get in touch with participants because they gave false contact information when they started the study

51

39

61

30

0.99

(0.87, 1.14)

 They may have trouble getting transportation for their appointments

68

22

71

20

0.99

(0.89, 1.09)

 They may have trouble being able to show up at a specific appointment time

62

28

72

19

1.05

(0.95, 1.16)

 They may have trouble getting to their appointment because of their work schedule

44

46

46

45

1.04

(0.89, 1.21)

 They may have trouble finding childcare so that they can go to their appointment

47

43

49

42

0.94

(0.79, 1.12)

 They may have concerns about confidentiality and privacy

43

47

60

31

1.09

(0.95, 1.26)

 They may be afraid that the staff would judge them if they are still using drugs

38

52

48

43

1.09

(0.91, 1.31)

 They may have stopped using drugs and no longer think the study is relevant to them

40

50

56

35

1.01

(0.86, 1.19)

 They are in a drug treatment or recovery facility and are unable to be contacted by research staff

49

41

60

31

1.09

(0.96, 1.25)

 Their friends, family, or partner may want them to stop participating

29

61

28

63

0.94

(0.71, 1.24)

  1. aHeroin as the preferred drug of choice is the referent group
  2. bThe level of response for each survey item was dichotomized into “selected” or “not selected” to generate prevalence ratios
  3. cCell sizes for “not selected” were < 10; analysis not performed
  4. * Significant at α = 0.05 level